LEADER 01694nam  2200433Ia 450 
001 9910699112903321
005 20230902162114.0
035   $a(CKB)5470000002400771
035   $a(OCoLC)466851132
035   $a(EXLCZ)995470000002400771
100   $a20091118d2006      ua             0
101 0 $aeng
135   $auran|||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 00$aGuidance for industry$b[electronic resource] $eformal dispute resolution : scientific and technical issues related to pharmaceutical CGMP
210  1$aRockville, MD :$cU.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research,$d[2006]
215   $a1 online resource (12 pages)
300   $a"Center for Biologics Evaluation and Research (CBER)."
300   $a"Center for Veterinary Medicine (CVM)."
300   $a"Office of Regulatory Affairs (ORA)."
300   $a"January 2006."
300   $a"Expiration date: 05/31/2008."
517   $aGuidance for industry 
606   $aDispute resolution (Law)$zUnited States
606   $aDrug factories$xGovernment policy$zUnited States
615  0$aDispute resolution (Law)
615  0$aDrug factories$xGovernment policy
712 02$aCenter for Drug Evaluation and Research (U.S.)
712 02$aCenter for Biologics Evaluation and Research (U.S.)
712 02$aCenter for Veterinary Medicine (U.S.)
712 02$aUnited States.$bFood and Drug Administration.$bOffice of Regulatory Affairs.
801  0$bGPO
801  1$bGPO
906   $aBOOK
912   $a9910699112903321
996   $aGuidance for industry$93434577
997   $aUNINA